Excessive visceral fat accumulation in advanced chronic obstructive pulmonary disease

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 423-430

  Furutate, Ryuko ^a   Ishii, Takeo ^a   Wakabayashi, Ritsuko ^a   Motegi, Takashi ^a   Yamada, Kouichi ^a   Gemma, Akihiko ^a   Kida, Kozui ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Abdominal obesity; Chronic obstructive pulmonary disease; Emphysema; Visceral fat

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPNEA; EMPHYSEMA; EXERCISE INTENSITY; EXERCISE TEST; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; SMOKING HABIT; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE; WALKING; ABDOMINAL OBESITY; BODY MASS; COMORBIDITY; FEMALE; HOSPITALIZATION; JAPAN; LUNG EMPHYSEMA; METABOLISM; PATHOPHYSIOLOGY; PREVALENCE; RADIOGRAPHY; RESPIRATORY SYSTEM; RISK FACTOR; SMOKING;

AGED; BODY MASS INDEX; COMORBIDITY; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; JAPAN; MALE; METABOLIC PHENOMENA; OBESITY, ABDOMINAL; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 84856022865     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S22885     Document Type: Article

References (39)

1. Agustí AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J. 2003; 21(2):347-360.
2. Mannino DM, Braman S. The epidemiology and economics of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2007;4(7): 502-506.
3. Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599-605.
4. McGarvey L P, John M, Anderson JA, Zvarich M, Wise RA. Ascertainment of cause-specifc mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax. 2007;62(5):411-415.
5. Pardo Silva MC, De Laet C, Nusselder WJ, Mamun AA, Peeters A. Adult obesity and number of years lived with and without cardiovascular disease. Obesity (Silver Spring). 2006;14(7):1264-1273.
6. Sin DD, Man S F. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514-1519.
7. Poulain M, Doucet M, Drapeau V, et al. Metabolic and inflammatory profile in obese patients with chronic obstructive pulmonary disease. Chron Respir Dis. 2008;5(1):35-41.
8. Watz H, Waschki B, Kristen A, et al. The metabolic syndrome in patients with chronic bronchitis and COPD: frequency and associated consequences for systemic inflammation and physical inactivity. Chest. 2009;136(4):1039-1046.
9. Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1): 39-48.
10. Matuzawa Y. Adiponectin: identification, physiology and clinical relevance in metabolic and vascular disease. Atheroscler Suppl. 2005; 6(2):7-14.
11. Yudkin JS. Adipose tissue, insulin action vascular disease: inflammatory signals. Int J Obes Relat Metab Disord. 2003;27(Suppl 3):S25-S28.
12. Molennar EA, Massaro JM, Jacques P F, et al. Association of lifestyle factors with abdominal subcutaneous and visceral adiposity: the Framingham Heart Study. Diabetes Care. 2009;32(3):505-510.
13. Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R. Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(9): 972-977.
14. Nicklas BJ, Penninx BW, Ryan AS, Berman DM, Lynch NA, Dennis KE. Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women. Diabetes Care. 2003; 26(5):1413-1420.
15. Global Initiative for Chronic Obstructive Lung Disease. Executive summary. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. http://www.goldcopd.com. Date last updated: March 2009. Accessed September 7, 2010.
16. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med. 1995;152(3):1107-1136.
17. Japanese Respiratory Society. The predicted values of spirometry and arterial blood gas analysis in Japanese. J Jpn Resp Soc. 2001; 39:Appendix. Japanese.
18. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
19. ATS Committee on Profciency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
20. Examination Committee of Criteria for 'Obesity Disease' in Japan, Japan Society for the Study of Obesity. New criteria for 'obesity disease' in Japan. Circ J. 2002;66(1):987-992.
21. Charlson ME, Pompei P, Ales KA, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
22. Almagro P, Calbo E, Ochoa de Echagüen A, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441-1448.
23. Motohashi N, Kimura K, Ishii T, et al. Emphysema on imaging is associated with quality of life in elderly patients with chronic obstructive pulmonary disease. Geriatr Gerontol Int. 2010;10(1):17-24.
24. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology. 1999;211(1):283-286.
25. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters E F. COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J. 2006; 15(2):84-91.
26. Ogawa E, Nakano Y, Ohara T, et al. Body mass index in male patients with COPD: correlation with low attenuation areas on CT. Thorax. 2009;64(1):20-25.
27. Kurosaki H, Ishii T, Motohashi N, et al. Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD. Intern Med. 2009; 48(1):41-48.
28. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med. 2005;99(Suppl B):S3-S10.
29. Eid AA, Ionescu AA, Nixon LS, et al. Inflammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164(8 Pt 1):1414-1418.
30. Serres I, Gautier V, Varray A, Préfaut C. Impaired skeletal muscle endurance related to physical inactivity and altered lung function in COPD patients. Chest. 1998;113(4):900-905.
31. Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574-580.
32. Wouters E F, Reynaert NL, Dentener MA, Vernooy HJ. Systemic and local inflammation in asthma and chronic obstructive pulmonary disease. Is there a connection? Proc Am Thorac Soc. 2009;6(8):638-647.
33. Després J P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006;444(7121):881-887.
34. Hosogai N, Fukuhara A, Oshima K, et al. Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes. 2007; 56(4):901-911.
35. Sauleda J, García-Palmer F, Wiesner RJ, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1413-1417.
36. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53-59.
37. Dallman M F, la Fleur SE, Pecoraro NC, Gomez F, Houshyar H, Akana S F. Minireview: glucocorticoids-food intake, abdominal obesity, and wealthy nations in 2004. Endocrinology. 2004;145(6):2633-2638.
38. O'Leary VB, Marchetti CM, Krishnan RK, Stetzer B P, Gonzalez F, Kirwan J P. Exercise-induced reversal of insulin resistance in obese elderly is associated with reduced visceral fat. J Appl Physiol. 2006; 100(5):1584-1589.
39. Burke GL, Bertoni AG, Shea S, et al. The impact of obesity on cardiovascular disease risk factors and subclinical vascular disease: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008;168(9): 928-935.